Biotech in India: Growth & Future

Introduction to Biotechnology in India

Biotechnology has come a long way since its inception, and today it is an integrated inter and multi-disciplinary science that combines biology, data, engineering, computation, and enterprise to solve real-world problems.

The Indian bioeconomy was worth USD 195.3 billion in 2025, and the country is rapidly becoming a healthcare-biotech ecosystem, with a focus on biologics, biosimilars, genomics, diagnostics, cell and gene therapies.

Biotech in Healthcare

Biotech in healthcare includes genomics and Next-Generation Sequencing, used for disease diagnosis and cancer profiling, as well as CRISPR and related tools that are opening opportunities in the management of inherited disorders, oncology, cell and gene therapy, rare disease workups, and outbreak tracking.

Bioinformatics and AI help analyze large biological datasets, discover biomarkers, predict drug targets, and reduce time from discovery to application.

Key Technologies

• Recombinant technologies
• Cell culture platforms
• Monoclonal antibodies
• mRNA-related platforms
• Process analytics and biologics manufacturing

Production of Covid vaccines in India demonstrated how biotech can move from the bench to the bedside and from the bedside to population-level impact in record time.

Success Stories and Future Directions

There are many Indian biotech success stories, including the Biotechnology Industry Research Assistance Council (BIRAC), which has supported hundreds of biotech companies, startups, and incubators, and has helped generate IPs and patents.

Indian biotech has today moved into advanced cell therapy, with indigenous CAR-T cell therapy at a fraction of the overseas cost being an example of high-end translational innovation.

The 2024 BioE3 Policy identifies precision biotherapeutics, including monoclonal antibodies, mRNA therapeutics, and cell and gene therapy, as a priority area, alongside bio-based APIs and enzymes, functional foods, and Bio-AI-enabled biomanufacturing.

Cancer Care and Genomics

Cancer care is probably where Indian biotechnology can have the clearest, early clinical impact, and genomics is also surging ahead, with the Genome India initiative having already made significant progress.

Conclusion and Future Outlook

For India, biotechnology is a national opportunity, a key pillar of future growth, and a strong biotech ecosystem can improve healthcare access, reduce dependence on imports, build domestic manufacturing capacity, and generate high-value jobs.

To achieve this, we need to translate science into products, services, and systems that people can use, which requires regulatory clarity, translational funding, and a culture that values implementation as much as publication.

Students should build skills in core science, technical skills, digital skills, and professional skills to succeed in the biotech industry.

The future belongs to people who can connect biology with technology and deliver usable solutions, and biotechnology is not one career, but an ecosystem of careers.

Implications for Readers in India

As the biotechnology sector in India continues to grow, it is essential for readers to understand the opportunities and challenges that come with it.

With the government's focus on biotechnology, there are numerous initiatives and programs being implemented to support the growth of the sector.

Readers can expect to see significant advancements in healthcare, agriculture, and environmental solutions, which will have a positive impact on their daily lives.

What to Watch Next

As the biotechnology sector in India continues to evolve, there are several areas to watch out for, including the development of new vaccines, the growth of the biotech startup ecosystem, and the increasing use of AI and machine learning in biotechnology.

The government's initiatives, such as Project SHAKTI, will also play a crucial role in shaping the future of biotechnology in India.

Read also: Measles Vaccine Hesitancy: The Major Roadblock to Global Eradication

Expert Perspective

According to experts, the biotechnology sector in India has the potential to become a global leader in the coming years.

With the right support and infrastructure, India can become a hub for biotechnology innovation, creating new opportunities for entrepreneurs, researchers, and scientists.

Background and Timeline

The biotechnology sector in India has a rich history, dating back to the 1970s.

Over the years, the sector has evolved significantly, with numerous breakthroughs and innovations.

Today, India is recognized as a global leader in biotechnology, with a strong focus on healthcare, agriculture, and environmental solutions.

Biotechnology and Healthcare in India

The Indian healthcare system is undergoing a significant transformation, with biotechnology playing a crucial role in this process.

Biotechnology is being used to develop new diagnostic tools, treatments, and vaccines, which are helping to improve healthcare outcomes and reduce costs.

Biotech Startups in India

India has a thriving biotech startup ecosystem, with numerous companies working on innovative solutions in areas such as healthcare, agriculture, and environmental sustainability.

These startups are being supported by government initiatives, such as the Biotechnology Industry Research Assistance Council (BIRAC), which provides funding and mentorship to early-stage companies.

Challenges and Opportunities

Despite the many opportunities in the biotechnology sector in India, there are also several challenges that need to be addressed.

These include the need for greater investment in research and development, the development of a more skilled workforce, and the creation of a more favorable regulatory environment.

Conclusion

In conclusion, the biotechnology sector in India is rapidly growing and has the potential to become a global leader in the coming years.

With the right support and infrastructure, India can become a hub for biotechnology innovation, creating new opportunities for entrepreneurs, researchers, and scientists.